Epigenetics and Sjögren's syndrome

Current Pharmaceutical Biotechnology

Volumn 13, Issue 10, 2012, Pages 2046-2053

  Le Dantec, Christelle ^a,b   Varin, Marie Michèle ^a,b   Brooks, Wesley H ^d,e   Pers, Jacques Olivier ^a,b,c   Youinou, Pierre ^a,b,c   Renaudineau, Yves ^a,b,c  

^a Universite de Brest   (France)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^c CHU MORVAN   (France)

^d Experimental HTS   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

DNA methylation; Epigenetics; Human endogenous retrovirus; microRNAs; Post translational modifications; Sj gren's syndrome

Indexed keywords

MICRORNA;

AGING; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; DISEASE PREDISPOSITION; DNA METHYLATION; ENDOGENOUS RETROVIRUS; EPIGENETICS; EXOCRINE GLAND; GENE EXPRESSION; GENE MUTATION; HIGH RISK POPULATION; HISTONE MODIFICATION; HUMAN; LYMPHOMA; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PROCESSING; SEQUENCE ANALYSIS; SJOEGREN SYNDROME; TREATMENT RESPONSE;

AGING; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; ENDOGENOUS RETROVIRUSES; EPIGENESIS, GENETIC; HUMANS; MICRORNAS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SJOGREN'S SYNDROME; TWIN STUDIES AS TOPIC;

HUMAN ENDOGENOUS RETROVIRUS;

EID: 84866689274     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112802273326     Document Type: Article

References (67)

1. Mavragani, C.P.; Moutsopoulos, H.M. The geoepidemiology of Sjögren's syndrome. Autoimmun. Rev., 2010, 9(5), A305-310.
2. Voulgarelis, M.; Dafni, U.G.; Isenberg, D.A.; Moutsopoulos, H.M. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis. Rheum., 1999, 42(8), 1765-1772.
3. Baimpa, E.; Dahabreh, I.J.; Voulgarelis, M.; Moutsopoulos, H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine. (Baltimore) 2009, 88(5), 284-293.
4. Tobón, G.J.; Renaudineau, Y.; Hillion, S.; Cornec, D.; Devauchelle-Pensec, V.; Youinou, P.; Pers, J.O. The FMS-like tyrosine kinase3-ligand, a mediator for B cell survival is also a marker for lymphoma in primary Sjögren's syndrome. Arthritis. Rheum., 2010, 62(11), 3447-3456.
5. Christodoulou, M.I.; Kapsogeorgou, E.K.; Moutsopoulos, H.M. Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J. Autoimmun., 2010, 34(4), 400-407.
6. Salomonsson, S.; Jonsson, M.V.; Skarstein, K.; Brokstad, KA.; Hjelmström, P.; Wahren-Herlenius, M.; Jonsson, R. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis. Rheum., 2003, 48(11), 3187-3201.
7. Cobb, B.L.; Lessard, C.J.; Harley, J.B.; Moser, K.L. Genes and Sjögren's syndrome. Rheum. Dis. Clin. North Am., 2008, 34(4), 847-868.
8. Mohammed, K.; Pope, J.; Le Riche, N.; Brintnell, W.; Cairns, E., Coles, R.; Bell, D.A. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis. J. Rheumatol., 2009, 36(9), 1937-1942.
9. Delgado-Vega, A.M.; Alarcón-Riquelme, M.E.; Kozyrev, S.V. Genetic associations in type I interferon related pathways with autoimmunity. Arthritis. Res. Ther., 2010, 12, S2.
10. Pers, J.O.; Tobón, G.J.; Jamin, C.; Renaudineau, Y.; Youinou, P. Conference Scene: Updating the highlights of Sjögren's Syndrome. Immunotherapy 2010, 2(1), 13-20.
11. Brooks, W.H.; Le Dantec, C.; Pers, J.O.; Youinou, P.; Renaudineau, Y. Epigenetics and autoimmunity. J. Autoimmun., 2010, 34(3), J207-219.
12. Webb, R.; Wren, J.D.; Jeffries, M.; Kelly, J.A.; Kaufman, K.M.; Tang, Y.; Frank, M.B.; Merrill, J.; Kimberly, R.P.; Edberg, J.C.; Ramsey-Goldman, R.; Petri, M.; Reveille, J.D.; Alarcón, G.S.; Vilá, L.M.; Alarcón-Riquelme. M.E.; James, J.A.; Vyse, T.J.; Moser, K.L.; Gaffney, P.M.; Gilkeson, G.S.; Harley, J.B.; Sawalha, A.H. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum., 2009, 60 (4), 1076-1084.
13. Dieker, J.; Muller, S. Epigenetic Histone Code and Autoimmunity. Clin. Rev. Allergy. Immunol., 2010, 39(1), 78-84.
14. Ballestar, E. Epigenetics Lessons from Twins: Prospects for Autoimmune Disease. Clin. Rev. Allergy Immunol., 2010, 39(1), 30-41.
15. Fraga, M.F.; Ballestar, E.; Paz, M.F.; Ropero, S.; Setien, F.; Ballestar, M.L.; Heine-Suñer, D.; Cigudosa, J.C.; Urioste, M.; Benitez, J.; Boix-Chornet, M.; Sanchez-Aguilera, A.; Ling, C.; Carlsson, E.; Poulsen, P.; Vaag, A.; Stephan, Z.; Spector, T.D.; Wu, Y.Z.; Plass, C.; Esteller, M. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA, 2005, 102(30), 10604-10609.
16. Javierre, B.M.; Fernandez, A.F.; Richter, J.; Al-Shahrour, F.; Martin-Subero, J.I.; Rodriguez-Ubreva, J.; Berdasco, M.; Fraga, M.F.; O'Hanlon, T.P.; Rider, L.G.; Jacinto, F.V.; Lopez-Longo, F.J.; Dopazo, J.; Forn, M.; Peinado, M.A.; Carreño, L.; Sawalha, A.H.; Harley, J.B.; Siebert, R.; Esteller, M.; Miller, F.W.; Ballestar, E. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome. Res., 2010, 20(2), 170-179.
17. Grolleau-Julius, A.; Ray, D.; Yung, R.L. The Role of Epigenetics in Aging and Autoimmunity. Clin. Rev. Allergy Immunol., 2010, 39(1), 42-50.
18. McCord, R.A.; Broccoli, D. Telomeric chromatin: roles in aging, cancer and hereditary disease. Mutat. Res., 2008, 647(1-2), 86-93.
19. Finkel, T.; Deng, C.X.; Mostoslavsky, R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460(7255), 587-591.
20. Sequeira, J.; Boily, G.; Bazinet, S.; Saliba, S.; He, X.; Jardine, K.; Kennedy, C.; Staines, W.; Rousseaux, C.; Mueller, R.; McBurney, M. sirt1-null mice develop an autoimmune-like condition. Exp. Cell. Res., 2008, 314(16), 3069-3074.
21. Grabiec, A.M.; Krausz, S.; de Jager, W.; Burakowski, T.; Groot, D.; Sanders. M.E.; Prakken, B.J.; Maslinski, W.; Eldering, E.; Tak, P.P.; Reedquist, K.A. Histone Deacetylase Inhibitors Suppress Inflammatory Activation of Rheumatoid Arthritis Patient Synovial Macrophages and Tissue. J. Immunol., 2010, 184(5), 2718-2728.
22. Lee, J.H.; Song, M.Y.; Song, E.K.; Kim, E.K.; Moon, W.S.; Han, M.K.; Park, J.W.; Kwon, K.B.; Park, B.H. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009, 58(2), 344-351.
23. Trenkmann, M.; Brock, M.; Ospelt, C.; Gay, S. Epigenetics in Rheumatoid Arthritis. Clin. Rev. Allergy Immunol., 2010, 39(1), 10-19.
24. Darwaza, A.; Lamey, P.J.; Connell, J.M. Hydrallazine-induced Sjögren's syndrome. Int. J. Oral. Maxillofac. Surg., 1988, 17(2), 92-93.
25. Taylor, J.A. Procainamide toxicity. Lancet 1968, 1(7549), 978.
26. Cannat, A.; Seligmann, M. Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin. Exp. Immunol., 1968, 3(1), 99-105.
27. Quddus, J.; Johnson, K.J.; Gavalchin, J.; Amento, E.P.; Chrisp, C.E.; Yung, R.L.; Richardson, B.C. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest., 1993, 92(1), 38-53.
28. Mazari, L.; Ouarzane, M.; Zouali, M. Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc. Natl. Acad. Sci. USA, 2007, 104(15), 6317-6322.
29. Lei, W.; Luo, Y.; Yan, K.; Zhao, S.; Li, Y.; Qiu, X.; Zhou, Y.; Long, H.; Zhao, M.; Liang, Y.; Su, Y.; Lu, Q. l. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J. Rheumatol. 2009, 38(5), 369-374.
30. Yin, H.; Zhao, M.; Wu, X.; Gao, F.; Luo, Y.; Ma, L.; Liu, S.; Zhang, G.; Chen, J.; Li, F.; Zuo, X.; Lu, Q. Hypomethylation and overexpression of CD70 (TNSF7) in CD4+ T cells of primary Sjögren's syndrome. J. Dermatol. Sci., 2010, 59(3), 198-203.
31. Chen, Y.; Gorelik, G.J.; Strickland, F.M.; Richardson, B.C. Decreased ERK and JNK signaling contribute to gene overexpression in "senescent" CD4+CD28-T cells through epigenetic mechanisms. J. Leukoc. Biol., 2010, 87(1), 137-145.
32. Lal, G.; Bromberg, J.S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009, 114(18), 3727-3735.
33. Garaud, S.; Le Dantec, C.; Berthou, C.; Lydyard, P.M.; Youinou, P.; Renaudineau, Y. Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J. Immunol., 2008, 181(3), 2010-2018.
34. Christodoulou, M.I.; Kapsogeorgou, E.K.; Moutsopoulos, N.M.; Moutsopoulos, H.M. Foxp3+ T-regulatory cells in Sjögren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am. J. Pathol., 2008, 173(5), 1389-1396.
35. Sarigul, M.; Yazisiz, V.; Bassorgun, C, I.; Ulker, M.; Avci, A, B.; Erbasan, F.; Ulker, M.; Avci, A.B.; Erbasan, F.; Gelen, T.; Gorczynski, R.M.; Terzioglu, E. The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome. Lupus 2010, 19(2), 138-145.
36. Youinou, P.; Mackenzie, L.; Le Masson, G.; Papadopoulos, N.M.;Jouquan, J., Pennec, Y.L.; Angelidis, P.; Katsikis, P.; Moutsopoulos, H.M., Lydyard, P.M. CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjögren's syndrome. J. Autoimmun. 1988, 1(2), 185-194.
37. Vaudo, G.; Bocci, E.B.; Shoenfeld, Y.; Schillaci, G.; Wu, R.; Del Papa, N.; Vitali, C.; Delle Monache, F.; Marchesi, S.; Mannarino, E.; Gerli, R. Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis. Rheum., 2005, 52(12), 3890-3897.
38. Katsifis, G.E.; Moutsopoulos, N.M.; Wahl, S.M. T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology. Clin. Rev. Allergy. Immunol., 2007, 32(3), 252-264.
39. Sharma, R.; Deshmukh, U.S.; Zheng, L.; Fu, S.M.; Ju, S.T. X-linked Foxp3 (Scurfy) mutation dominantly inhibits submandibular gland development and inflammation respectively through adaptive and innate immune mechanisms. J. Immunol., 2009, 183(5), 3212-3218.
40. Brookes, S.M.; Pandolfino, Y.A.; Mitchell, T.J.; Venables, P.J.; Shattles, W.G.; Clark, D.A.; Entwistle, A.; Maini, R.N. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br. J. Rheumatol., 1992, 31(11), 735-742.
41. Yamano, S.; Renard, J.N.; Mizuno, F.; Narita, Y.; Uchida, Y.; Higashiyama, H.; Sakurai, H.; Saito, I. Retrovirus in salivary glands from patients with Sjögren's syndrome. J. Clin. Pathol., 1997, 50(3), 223-230.
42. Renaudineau, Y.; Vallet, S.; Le Dantec, C.; Hillion, S.; Saraux, A.; Youinou, P. Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes. Genes. Immun., 2005, 6(8), 663-671.
43. Renaudineau, Y.; Garaud, S.; Le Dantec, C.; Alonso-Ramirez, R.; Daridon, C.; Youinou, P. Autoreactive B Cells and Epigenetics. Clin. Rev. Allergy Immunol. 2010, 39(1), 85-94.
44. Perron, H.; Lang, A. The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clin. Rev. Allergy. Immunol., 2010, 39(1), 51-61.
45. Fernandez, D.R.; Telarico, T.; Bonilla, E.; Li, Q., Banerjee, S., Middleton, F.A.; Phillips, P.E.; Crow, M.K.; Oess, S.; Muller Esterl, W.; Perl, A. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J. Immunol. 2009, 182(4), 2063-2073.
46. Renaudineau, Y.; Hillion, S.; Saraux, A.; Mageed, RA.; Youinou, P. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes. Blood 2005, 106(8), 2781-2789.
47. Garaud, S.; Le Dantec, C.; Jousse-Joulin, S.; Hanrotel-Saliou, C.; Saraux, A.; Mageed, R.A.; Youinou, P.; Renaudineau, Y. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J. Immunol., 2009, 182(9), 5623-3562.
48. Hippen, K.L.; Tze, L.E.; Behrens, T.W. CD5 maintains tolerance in anergic B cells. J. Exp. Med., 2000, 191(5), 883-890.
49. Wouters, D.; van Schouwenburg, P.; van der Horst, A.; de Boer, M.; Schooneman, D.; Kuijpers, T.W.; Aarden, L.A.; Hamann, D. High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's. Mol. Immunol., 2009, 46(4), 592-600.
50. Moyes, D.L.; Martin, A.; Sawcer, S.; Temperton, N.; Worthington, J.; Griffiths, D.J.; Venables, P.J. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 2005, 86(3), 337-341.
51. Toso, A.; Aluffi, P.; Capello, D.; Conconi, A.; Gaidano, G.; Pia, F. Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands. Head Neck 2009, 31(9), 1181-1187.
52. Brooks, W.H. X Chromosome Inactivation and Autoimmunity. Clin. Rev. Allergy. Immunol. 2010, 39(1), 20-29.
53. Ozcelik, T. X chromosome inactivation and female predisposition to autoimmunity. Clin. Rev. Allergy. Immunol., 2008, 34(3), 348-351.
54. Lu, Q.; Wu, A.; Tesmer, L.; Ray, D.; Yousif, N.; Richardson, B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol., 2007, 179(9), 6352-6358.
55. Pauley, K.M.; Stewart, C.M.; Gauna, A.E.; Dupre, L.C.; Kuklani, R.; Chan, A.L.; Pauley, B.A.; Reeves, W.H.; Chan, E.K.; Cha, S. Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Eur. J. Immunol., 2011, 41(7), 2029-2039.
56. Tsitsiou, E.; Lindsay, M.A. microRNAs and the immune response. Curr. Opin. Pharmacol. 2009, 9(4), 514-520.
57. Alevizos, I.; Illei, G.G. MicroRNAs in Sjogren's syndrome as a prototypic autoimmune disease. Autoimmun. Rev., 2010, 9(9), 618-621.
58. Chan, E.K.; Satoh, M.; Pauley, K.M. Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? Arthritis Rheum., 2009, 60(4), 912-915.
59. Reed, J.H.; Jackson, M.W.; Gordon, T.P. B cell apotopes of the 60-kDa Ro/SSA and La/SSB autoantigens. J. Autoimmun., 2008, 31(3), 263-267.
60. Terzoglou, A.G.; Routsias, J.G.; Avrameas, S.; Moutsopoulos, H.M.; Tzioufas, A.G. Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases. Clin. Exp. Immunol., 2006, 144(3), 432-439.
61. Terzoglou, A.G.; Routsias, J.G.; Moutsopoulos, H.M.; Tzioufas, A.G. Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding. Clin. Exp. Immunol., 2006, 146(1), 60-65.
62. Scofield, R.H.; Kurien, B.T.; Ganick, S.; McClain, M.T.; Pye, Q.; James, J.A.; Schneider, R.I.; Broyles, R.H.; Bachmann, M.; Hensley, K. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic. Biol. Med., 2005, 38(6), 719-728.
63. Stea, E.A.; Routsias, J.G.; Samiotaki, M.; Panayotou, G.; Papalambros, E.; Moutsopoulos, H.M.; Tzioufas, A.G. Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets. Clin. Exp. Immunol., 2007, 147(1), 81-89.
64. Klareskog, L.; Rönnelid, J.; Lundberg, K.; Padyukov, L.; Alfredsson, L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 2008, 26 651-675.
65. Renaudineau, Y. The Revolution of Epigenetics in the Field of Autoimmunity. Clin. Rev. Allergy Immunol., 2010, 39 1-2.
66. Lu, Q.; Renaudineau, Y.; Cha, S.; Ilei, G.; Brooks, W.H.; Selmi, C.; Tzioufas, A.; Pers, J.O.; Bombardieri, S.; Gershwin, M.E.; Gay, S.; Youinou, P. Epigenetics in autoimmune disorders: Highlights of the 10th Sjögren's Syndrome Symposium. Autoimmun. Rev., 2010, 9(9), 627-630.
67. Vinuesa, C.G.; Rigby, R.J.; Yu, D. Logic and extent of miRNAmediated control of autoimmune gene expression. Int. Rev. Immunol., 2009, 28(3-4), 112-138.